Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15367881 | 0.79 | ALDH1A1 (0.68) | ALDH1A1MEN1KMT2AMAPTHPGD | |
| SCHEMBL13902572 | 0.78 | ALDH1A1 (0.66) | ALDH1A1MEN1KMT2AMAPTHPGD | |
| SCHEMBL8534455 | 0.76 | ALDH1A1 (1.00) | ALDH1A1MEN1KMT2AMAPTHPGD | |
| SCHEMBL125012 | 0.74 | MEN1 (0.36) | ALDH1A1MEN1KMT2A | |
| SCHEMBL21877489 | 0.74 | ALDH1A1 (0.60) | ALDH1A1MEN1KMT2AMAPTHPGD | |
| SCHEMBL22522 | 0.70 | ALDH1A1 (0.52) | ALDH1A1MEN1KMT2AMAPTHPGD | |
| SCHEMBL7102666 | 0.70 | ALDH1A1 (0.52) | ALDH1A1MEN1KMT2AMAPTHPGD | |
| SCHEMBL13284544 | 0.69 | LMNA (0.54) | ALDH1A1MEN1KMT2AMAPTHPGD | |
| SCHEMBL20392114 | 0.69 | NPC1 (0.66) | ALDH1A1MEN1KMT2AMAPTHPGD | |
| SCHEMBL271129 | 0.68 | ALDH1A1 (0.50) | ALDH1A1MEN1KMT2AMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 692 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4715006-A2 | UNSATURATED SCORCH RETARDERS | Nouryon Chemicals International B.V. (NL) | 2026-03-25 | — | — | EP | claimed |
| US-20260078088-A1 | UNSATURATED SCORCH RETARDERS | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2026-03-19 | — | — | US | claimed |
| US-20250352444-A1 | Antimicrobial mixtures | SYMRISE AG (DE) | 2025-11-20 | — | — | US | claimed |
| US-20250325463-A1 | COMPOSITIONS (III) | SYMRISE AG (DE) | 2025-10-23 | — | — | US | claimed |
| EP-4525822-A1 | ANTIMICROBIAL MIXTURES | Symrise AG (DE) | 2025-03-26 | — | — | EP | claimed |
| WO-2025030129-A2 | AEROSOL SPRAY DEVICE, INSECTICIDE COMPOSITION, AND METHOD OF USE | UNITED INDUSTRIES CORPORATION (US) | 2025-02-06 | — | — | WO | claimed |
| EP-4472606-A1 | COMPOSITIONS (III) | Symrise AG (DE) | 2024-12-11 | — | — | EP | claimed |
| CN-119097706-A | Natural product for preventing and treating vascular calcification and application thereof | 江南大学 | 2024-12-10 | — | — | CN | claimed |
| US-20240358611-A1 | COMPOSITIONS | SYMRISE AG (DE) | 2024-10-31 | — | — | US | claimed |
| CN-118724718-A | Preparation method of trimethylhydroquinone diester | 万华化学集团股份有限公司 | 2024-10-01 | — | — | CN | claimed |
| EP-0691325-B1 | Asymmetric hydrogenation of ketoisophorone derivatives | HOFFMANN LA ROCHE (CH) | 1998-04-15 | — | — | EP | claimed |
| EP-0739331-A4 | METHOD OF MAKING KETOISOPHORONE VIA OXIDATION OF ISOPHORONE WITH TERT-BUTYL HYDROPEROXIDE | ARISTECH CHEMICAL CORP (US) | 1997-12-10 | — | — | EP | claimed |
| EP-0739331-A1 | METHOD OF MAKING KETOISOPHORONE VIA OXIDATION OF ISOPHORONE WITH TERT-BUTYL HYDROPEROXIDE | ARISTECH CHEMICAL CORPORATION (US) | 1996-10-30 | — | — | EP | claimed |
| US-5545761-A | USING OXIDATION CATALYSTS | ARISTECH CHEMICAL CORPORATION (US) | 1996-08-13 | — | — | US | claimed |
| US-5543559-A | USING A RHODIUM CATALYST HAVING AN OPTICALLY ACTIVE PIPHOSPHINE LIGAND | HOFFMAN-LA ROCHE INC. (US) | 1996-08-06 | — | — | US | claimed |
| CN-1127741-A | Asymmetrical hydrogenation of ketoisophorone derivatives | HOFFMANN LA ROCHE (CH) | 1996-07-31 | — | — | CN | claimed |
| WO-1996015094-A1 | METHOD OF MAKING KETOISOPHORONE VIA OXIDATION OF ISOPHORONE WITH TERT-BUTYL HYDROPEROXIDE | ARISTECH CHEMICAL CORPORATION (US) | 1996-05-23 | — | — | WO | claimed |
| US-4046813-A | Process for producing ketoisophorone | HOFFMANN-LA ROCHE INC. (US) | 1977-09-06 | — | — | US | claimed |
| US-3988205-A | BY FERMENTATIVELY HYDROGENATING AND REDUCING KETOISOPHORONE | HOFFMANN-LA ROCHE INC. (US) | 1976-10-26 | — | — | US | claimed |
| US-3960966-A | Ketoisophorone manufacture | HOFFMANN-LA ROCHE INC. (US) | 1976-06-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240358611-A1 | COMPOSITIONS | AZI2, NISCH, CIP2A | ALDH1A1 815/4885MEN1 2148/4885KMT2A 617/4885 |
| US-20260078088-A1 | UNSATURATED SCORCH RETARDERS | SCO2, OXER1, CBR1 | ALDH1A1 539/4885MEN1 4164/4885KMT2A 4328/4885 |
| US-20250352444-A1 | Antimicrobial mixtures | LRBA, MGLL, TAS2R50 | ALDH1A1 1462/4885MEN1 3090/4885KMT2A 4634/4885 |
| US-20250325463-A1 | COMPOSITIONS (III) | NISCH, TAS1R3, TAS2R3 | ALDH1A1 1377/4885MEN1 1480/4885KMT2A 2977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.